CRIX International Eases Pharmaceutical Processes with Red Hat and Alfresco Solutions

Consortium launches CRIX Collaborative Platform using Red Hat, JBoss products and Alfresco

RALEIGH, NC – August 13, 2008 – Red Hat (NYSE: RHT), the world's leading provider of open source solutions, and Alfresco Software today announced that the Clinical Research Information Exchange (CRIX), a non-profit collaborative consortium that includes Eli Lilly, AstraZeneca, Pfizer and Novartis in the development of new drug therapies, has launched a secure and standards-based electronic information exchange for clinical research information that is based on a combination of Red Hat, JBoss and Alfresco solutions. The CRIX Collaboration Platform was developed using Red Hat Enterprise Linux, Alfresco Enterprise Content Management (ECM), JBoss Enterprise Portal Platform and JBoss Enterprise Application Platform, including JBoss Hibernate.

The process behind bringing new drugs to market has always been a complex, costly and labor-intensive process that involves extensive paperwork. Though some of the large bio-pharma businesses have implemented proprietary IT systems that attempt to automate most or all of the process, frequently this information is collected, processed and exchanged manually.

“What we absolutely needed was a platform that could be used across this very broad arena of clinical research that was independent of business processes, legal documentations, intellectual property protections and marketing strategies,” said Mark Vermette, product manager for CRIX International. “And the ultimate goal of such a platform would be to enable delivery of faster, more secure and more effective drugs to patients.”

In 2007, CRIX International was formed and the CRIX project was placed under its jurisdiction. The organization embarked on the CRIX Collaborative Platform with Rivet Logic, an open source systems integrator. The team decided to utilize open source solutions to ensure that the platform would be based upon established standards and would enable easy participation that could be attributed back to the industry.

“It was quickly clear that we wanted Red Hat Enterprise Linux and JBoss Enterprise Middleware to support our efforts. The biggest reasons for choosing Red Hat were the technical excellence of its products and its legendary support. Its reputation is well-deserved,” said Vermette.

With a combination of Red Hat Enterprise Linux, Alfresco ECM, JBoss Enterprise Portal Platform and JBoss Enterprise Application Platform, including JBoss Hibernate, the CRIX Collaborative Platform was launched in June 2008 and delivers a shared knowledgebase that is designed to enable increased opportunities for collaboration and facilitate economies of scale unprecedented in the pharmaceuticals industry. The platform should help to lower transaction fees, reduce human error in terms of manual data entry, shorten processing time for new therapies and represents a groundbreaking collaboration tool for the industry.

“Alfresco provides us with enterprise-scale content management solution, based entirely on open standards, enabling consortium members to accelerate collaboration and information flows for clinical research,” said Vermette.

Future plans for the CRIX Collaborative Platform include incorporating JBoss jBPM. “The pharmaceutical industry has some very complex regulatory requirements and historically has binders and binders of paper documents with complicated rules on who gets to author them, how they are edited and how the content is controlled,” said Vermette. “The JBoss jBPM Framework is very sophisticated technology that will provide these capabilities and should be the ‘tipping point’ for getting organizations to adopt the CRIX Collaborative Platform.”

Read the CRIX case study on the Red Hat site. For more news about Red Hat, visit www.redhat.com. For more news, more often, visit www.press.redhat.com.

Alfresco is available for download.

About Red Hat, Inc.
Red Hat, the world's leading open source solutions provider, is headquartered in Raleigh, NC with over 50 satellite offices spanning the globe. CIOs have ranked Red Hat first for value in Enterprise Software for four consecutive years in the CIO Insight Magazine Vendor Value study. Red Hat provides high-quality, affordable technology with its operating system platform, Red Hat Enterprise Linux, together with applications, management and Services Oriented Architecture (SOA) solutions, including JBoss Enterprise Middleware. Red Hat also offers support, training and consulting services to its customers worldwide. Learn more: http://www.redhat.com.

About Alfresco Software, Inc.
Alfresco Software, Inc. is the first and leading open source alternative for enterprise content management. It is the first company to bring the power of open source to the enterprise content management market, enabling unprecedented scale and a much lower total cost of ownership than proprietary systems. Founded by a team of content management veterans that includes the co-founder of Documentum, John Newton, and former COO of Business Objects, John Powell, Alfresco is based in London. For more information, go to www.alfresco.com

Forward-Looking Statements
Certain statements contained in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: risks related to the integration of acquisitions; the ability of the Company to effectively compete; the inability to adequately protect Company intellectual property and the potential for infringement or breach of license claims of or relating to third party intellectual property; risks related to data and information security vulnerabilities; ineffective management of, and control over, the Company's growth and international operations; adverse results in litigation; and changes in and a dependence on key personnel, as well as other factors contained in our most recent Quarterly Report on Form 10-Q (copies of which may be accessed through the Securities and Exchange Commission's website at http://www.sec.gov), including those found therein under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations". In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.